The case for & against
Bull & Bear analysis
Ansell Limited (ASX:ANN) is a leading global provider of protective solutions, specializing in personal protective equipment (PPE) and industrial safety products. The company operates in the essential sector of occupational health and safety, focusing on manufacturing high-quality products across multiple industries, including healthcare, industrial, and consumer sectors. Ansell benefits from a strong market position, particularly with its protective gloves, which positions it favorably in the growing emphasis on workplace safety and hygiene, especially in light of global health challenges.
Bull says
- ↑FY26 statutory net profit rose 105.3% to US$208.6M on cost efficiencies
- ↑Declared final dividend of 41.5¢, total FY26 payout 68.1¢ (45% of earnings)
- ↑FY27 adjusted EPS guidance 158–170¢ vs 148.6¢ in FY26 signals sustained growth
- ↑Leverage reduced and margins expanded, underpinning financial stability
- ↑Kimberly-Clark PPE integration to drive synergies and market expansion
- ↑Strong earnings yield, robust profitability, positive momentum and low leverage risk
Bear says
- ↓Heavy reliance on healthcare and industrial segments may cause revenue swings in downturns
- ↓EPS guidance cut risk could trigger analyst downgrades and share underperformance
- ↓Significant PPE revenue concentration exposes Ansell to regulatory and market shifts
- ↓Intense competition may pressure pricing and erode profit margins
- ↓Execution delays in Kimberly-Clark integration could undermine projected benefits
- ↓Elevated short interest and weaker liquidity factors suggest potential bearish sentiment